SWK Holdings Corporation

Equities

SWKH

US78501P2039

Corporate Financial Services

Delayed Nasdaq 10:45:01 2024-03-28 am EDT 5-day change 1st Jan Change
17.73 USD +1.78% Intraday chart for SWK Holdings Corporation -0.89% +1.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tranche Update on SWK Holdings Corporation's Equity Buyback Plan announced on May 16, 2023. CI
Transcript : SWK Holdings Corporation, Q4 2023 Earnings Call, Mar 21, 2024
Earnings Flash (SWKH) SWK HOLDINGS Reports Q4 Revenue $9.9M MT
SWK Holdings Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
SWK Holdings Corporation Announces Resignation of Yvette Heinrichson as Chief Financial Officer, Effective February 13, 2024 CI
Journey Medical Signs Credit Facility of up to $20 Million MT
Transcript : SWK Holdings Corporation, Q3 2023 Earnings Call, Nov 09, 2023
Earnings Flash (SWKH) SWK HOLDINGS CORPORATION Posts Q3 Revenue $9M MT
Tranche Update on SWK Holdings Corporation's Equity Buyback Plan announced on May 16, 2023. CI
SWK Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
SWK Holdings Corporation Increases Revolving Credit Facility to $60 Million CI
SWK Closes $30 Million Debt Offering MT
SWK Holdings Prices $30 Million Senior Notes Offering MT
SWK Holdings Plans $30 Million Senior Notes Offering MT
Tranche Update on SWK Holdings Corporation's Equity Buyback Plan announced on May 19, 2022. CI
Transcript : SWK Holdings Corporation, Q2 2023 Earnings Call, Aug 09, 2023
Earnings Flash (SWKH) SWK HOLDINGS CORPORATION Posts Q2 Revenue $9.5M MT
SWK Holdings Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Tranche Update on SWK Holdings Corporation's Equity Buyback Plan announced on May 16, 2023. CI
SWK Holdings Secures New Credit Facility with $45 Million Committed at Close MT
Transcript : SWK Holdings Corporation - Shareholder/Analyst Call
SWK Holdings Corporation announces an Equity Buyback for $10 million worth of its shares. CI
SWK Holdings Corporation authorizes a Buyback Plan. CI
SWK Holdings Corporation's Equity Buyback announced on May 19, 2022, has expired with 113,639 shares, representing 0.89% for $2.03 million. CI
Transcript : SWK Holdings Corporation, Q1 2023 Earnings Call, May 11, 2023
Chart SWK Holdings Corporation
More charts
SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies, the Peptelligence platform.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
17.42 USD
Average target price
24 USD
Spread / Average Target
+37.77%
Consensus
  1. Stock
  2. Equities
  3. Stock SWK Holdings Corporation - Nasdaq
  4. News SWK Holdings Corporation
  5. SWK : ' Subsidiary, Enteris BioPharma, Receives $2.5Million Milestone Payment from Cara Therapeutics